New e-book: The value of in-house genomic profiling for precision oncology!
sponsored by Thermo Fisher Scientific
In this new e-book by Thermo Fisher Scientific, precision medicine experts from around the world offer their thoughts on the benefits – and drawbacks – of keeping comprehensive genomic profiling for cancer in-house. With a focus on comprehensive genomic profiling, these experts illustrate the strengths that in-house molecular testing can bring to the laboratory.